←Back to Expert Scholars
Translational Medicine / 转化医学Plasma NGS in Lung Cancer
David Planchard
MD, PhD
🏢Gustave Roussy🌐France
Head, Thoracic Cancer Committee
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
David Planchard led BRAF-directed therapy trials in NSCLC and leverages plasma NGS for rare driver identification. His work established dabrafenib-trametinib for BRAF V600E lung cancer. He leads European liquid biopsy initiatives in thoracic oncology.
Share:
🧪Research Fields 研究领域
BRAF NSCLC
Dabrafenib-trametinib
Liquid biopsy
European trials
Targeted therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 David Planchard 的研究动态
Follow David Planchard's research updates
留下邮箱，当我们发布与 David Planchard（Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment